Insider Transactions in Q2 2021 at Globus Medical Inc (GMED)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Keith W Pfeil SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,479
-100.0%
|
$2,060,925
$75.04 P/Share
|
|
Jun 25
2021
|
Keith W Pfeil SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,479
+50.0%
|
$1,401,429
$51.46 P/Share
|
|
May 10
2021
|
James R Tobin |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,775,000
$71.96 P/Share
|
|
May 10
2021
|
James R Tobin |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$1,075,000
$43.77 P/Share
|
|
May 05
2021
|
Keith W Pfeil SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,021
-100.0%
|
$376,575
$75.0 P/Share
|
|
May 05
2021
|
Keith W Pfeil SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,021
+50.0%
|
$246,029
$49.65 P/Share
|
|
Apr 26
2021
|
David M Demski President, CEO |
SELL
Open market or private sale
|
Direct |
144,263
-100.0%
|
$10,242,673
$71.5 P/Share
|
|
Apr 26
2021
|
David M Demski President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
144,263
+40.68%
|
$3,895,101
$27.79 P/Share
|
|
Apr 23
2021
|
David M Demski President, CEO |
SELL
Open market or private sale
|
Direct |
121,259
-100.0%
|
$8,609,389
$71.59 P/Share
|
|
Apr 23
2021
|
David M Demski President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
121,259
+34.99%
|
$5,092,878
$42.48 P/Share
|